![Sandy Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandy Lee
Directeur/Membre du Conseil chez
MYCENAX BIOTECH INC.
Profil
Sandy Lee is currently the Director at Mycenax Biotech, Inc. and also holds the position of Senior Vice President at CIDC Consultants, Inc. In the past, Ms. Lee worked as a Director at Maxigen Biotech, Inc. and InnoPharmax, Inc. where she held the position of Director from 2019 to 2022.
Ms. Lee is a graduate of San Jose State University.
Postes actifs de Sandy Lee
| Sociétés | Poste | Début |
|---|---|---|
| MYCENAX BIOTECH INC. | Directeur/Membre du Conseil | 15/08/2019 |
CIDC Consultants, Inc.
 CIDC Consultants, Inc. Investment ManagersFinance CIDC Consultants is an active manager which invests in companies in the biotech (drug development, diagnostic kits, health care, advanced technology) and electronics/IT (IC design, wireless communications, broadband communications, online multimedia content, microelectromechanical devices, nanotechnology) sectors in Taiwan and internationally. The firm makes direct and indirect investments in companies, aiming to create value for shareholders and for the investee company. They partner with their affiliates to leverage their capital, business relationships, industry expertise and information network and invite their investment partners or shareholders to participate in the investment by taking significant ownership positions in their investee companies. When investee companies and shareholders or affiliated companies have an upstream/downstream relationship or have complementary business strategies or resources, CIDC Consultants aims to achieve mutual advantage for all parties, assisting them to achieve resource integration or to jointly pursue strategic projects. The firm utilizes relationships with foreign partners to incubate new projects, introduce new technologies, new products and business approaches suited to Taiwan's development. | Membre du Comité d'Investissement | - |
Anciens postes connus de Sandy Lee
| Sociétés | Poste | Fin |
|---|---|---|
| INNOPHARMAX INC. | Directeur/Membre du Conseil | 19/04/2022 |
| MAXIGEN BIOTECH INC. | Directeur/Membre du Conseil | - |
Formation de Sandy Lee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
San Jose State University
 San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CIDC Consultants, Inc.
CIDC Consultants, Inc. Investment ManagersFinance CIDC Consultants is an active manager which invests in companies in the biotech (drug development, diagnostic kits, health care, advanced technology) and electronics/IT (IC design, wireless communications, broadband communications, online multimedia content, microelectromechanical devices, nanotechnology) sectors in Taiwan and internationally. The firm makes direct and indirect investments in companies, aiming to create value for shareholders and for the investee company. They partner with their affiliates to leverage their capital, business relationships, industry expertise and information network and invite their investment partners or shareholders to participate in the investment by taking significant ownership positions in their investee companies. When investee companies and shareholders or affiliated companies have an upstream/downstream relationship or have complementary business strategies or resources, CIDC Consultants aims to achieve mutual advantage for all parties, assisting them to achieve resource integration or to jointly pursue strategic projects. The firm utilizes relationships with foreign partners to incubate new projects, introduce new technologies, new products and business approaches suited to Taiwan's development. | Finance |
Mycenax Biotech, Inc.
 Mycenax Biotech, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Maxigen Biotech, Inc.
 Maxigen Biotech, Inc. BiotechnologyHealth Technology Provides biomedical materials and skincare products | Health Technology |
InnoPharmax, Inc.
 InnoPharmax, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
